PL2950783T3 - Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę - Google Patents

Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Info

Publication number
PL2950783T3
PL2950783T3 PL14704747T PL14704747T PL2950783T3 PL 2950783 T3 PL2950783 T3 PL 2950783T3 PL 14704747 T PL14704747 T PL 14704747T PL 14704747 T PL14704747 T PL 14704747T PL 2950783 T3 PL2950783 T3 PL 2950783T3
Authority
PL
Poland
Prior art keywords
carboxymethylcellulose
sodium hyaluronate
artificial tears
tears
artificial
Prior art date
Application number
PL14704747T
Other languages
English (en)
Inventor
Bereth J Beard
Wendy M Blanda
David A Marsh
Peter A Simmons
Joseph G Vehige
Liu Haixia
Steven S Matsumoto
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PL2950783T3 publication Critical patent/PL2950783T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL14704747T 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę PL2950783T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361759710P 2013-02-01 2013-02-01
US201361785857P 2013-03-14 2013-03-14
EP14704747.6A EP2950783B1 (en) 2013-02-01 2014-02-03 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
PCT/US2014/014505 WO2014121232A1 (en) 2013-02-01 2014-02-03 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose

Publications (1)

Publication Number Publication Date
PL2950783T3 true PL2950783T3 (pl) 2019-11-29

Family

ID=50113045

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19151359T PL3517100T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę
PL14704747T PL2950783T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL19151359T PL3517100T3 (pl) 2013-02-01 2014-02-03 Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę

Country Status (23)

Country Link
US (5) US20140221309A1 (pl)
EP (2) EP3517100B1 (pl)
JP (2) JP6527468B2 (pl)
KR (1) KR102227202B1 (pl)
CN (2) CN111419794A (pl)
AU (2) AU2014212025A1 (pl)
BR (1) BR112015018414B1 (pl)
CA (1) CA2898217C (pl)
CY (1) CY1124054T1 (pl)
DK (2) DK2950783T3 (pl)
ES (2) ES2741141T3 (pl)
HR (1) HRP20191382T1 (pl)
HU (2) HUE052793T2 (pl)
LT (1) LT2950783T (pl)
MX (1) MX367461B (pl)
PL (2) PL3517100T3 (pl)
PT (2) PT2950783T (pl)
RS (1) RS59271B1 (pl)
RU (1) RU2687275C2 (pl)
SA (1) SA517381008B1 (pl)
SI (2) SI2950783T1 (pl)
WO (1) WO2014121232A1 (pl)
ZA (1) ZA201505026B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2837626T3 (es) 2013-07-10 2021-07-01 Matrix Biology Inst Composiciones de hialuronano con alta elasticidad y usos de las mismas
US9463201B2 (en) * 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
US9694084B2 (en) 2014-12-23 2017-07-04 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
RU2020123728A (ru) 2015-09-24 2021-01-18 Матрикс Байолэджи Инститьют Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
US20180338911A1 (en) * 2015-10-28 2018-11-29 David B. Welch Eye Drops
ES2621877B1 (es) * 2016-01-04 2018-05-04 Agencia Pública Empresarial Sanitaria Hospital De Poniente Solución para resección endoscópica
US10632202B2 (en) * 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
RS67599B1 (sr) * 2017-06-09 2026-01-30 Omnivision Gmbh Kompozicija za lečenje suvog oka
WO2019202017A1 (en) * 2018-04-18 2019-10-24 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
CN112714644B (zh) * 2018-09-20 2024-03-29 香港科技大学 滴眼剂组合物
KR102051356B1 (ko) * 2019-01-03 2019-12-03 (주)휴온스 고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
WO2020157570A1 (en) 2019-01-31 2020-08-06 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
WO2022189548A1 (en) 2021-03-10 2022-09-15 Bausch + Lomb Ireland Limited Contact lens treating solution
WO2025175150A1 (en) * 2024-02-16 2025-08-21 Allergan, Inc. Enhanced artificial tear formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
EP1174463A4 (en) * 1999-02-19 2008-04-16 Denki Kagaku Kogyo Kk GEL FROM HYALURONIC ACID, METHOD FOR THE PRODUCTION THEREOF, AND THIS CONTAINING MEDICINE MATERIAL
US6472379B1 (en) 1999-03-15 2002-10-29 Trustees Of Boston University Angiogenesis inhibition
PL356093A1 (pl) * 1999-11-09 2004-06-14 Alcon Inc. Hydroksyeikozatetraeniany, sole, kompozycje i sposoby ich zastosowania w leczeniu zespołu suchego oka
ATE283715T1 (de) * 1999-12-17 2004-12-15 Genzyme Corp Chirurgische prothese
CN1485395A (zh) * 2002-09-25 2004-03-31 宋海涛 一种环保型“冷热液”
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
JP2006052160A (ja) * 2004-08-10 2006-02-23 Rohto Pharmaceut Co Ltd ドライアイ治療用眼科組成物
JP2006143590A (ja) * 2004-10-21 2006-06-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP2008519846A (ja) * 2004-11-09 2008-06-12 アドバンスト メディカル オプティクス， インコーポレーテッド 眼科用溶液
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
AR062046A1 (es) * 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
CN101534793A (zh) * 2006-11-06 2009-09-16 诺瓦提斯公司 眼科器件及其制造和使用方法
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
KR100827400B1 (ko) * 2008-06-24 2008-05-06 김정춘 파이프 연결구를 갖는 수도계량기 및 그 제조방법
KR100938500B1 (ko) * 2008-06-24 2010-01-28 주식회사 디에이치피코리아 안과질환 예방 및 치료용 점안제 조성물
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
EP2349232A1 (en) * 2008-10-20 2011-08-03 Allergan, Inc. Ophthalmic compositions useful for improving visual acuity
BR112012014260A2 (pt) * 2009-12-15 2015-09-15 Foresight Biotherapeutics Inc composições de iodopovidona oftalmológica não irritante
CN101785852A (zh) * 2010-01-21 2010-07-28 孙杰 一种真皮层微量介入美容抗衰除皱制剂与方法
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂

Also Published As

Publication number Publication date
DK2950783T3 (da) 2019-07-22
AU2018260857A1 (en) 2018-11-22
US20260069627A1 (en) 2026-03-12
PL3517100T3 (pl) 2021-04-19
SI3517100T1 (sl) 2021-02-26
BR112015018414B1 (pt) 2022-11-08
BR112015018414A2 (pt) 2017-07-18
WO2014121232A1 (en) 2014-08-07
US20160235780A1 (en) 2016-08-18
LT2950783T (lt) 2019-10-25
SA517381008B1 (ar) 2019-08-31
DK3517100T3 (da) 2020-12-14
JP2016507529A (ja) 2016-03-10
AU2018260857B2 (en) 2020-05-07
RS59271B1 (sr) 2019-10-31
EP2950783A1 (en) 2015-12-09
EP3517100A1 (en) 2019-07-31
MX367461B (es) 2019-08-21
PT2950783T (pt) 2019-08-21
ZA201505026B (en) 2016-07-27
ES2741141T3 (es) 2020-02-10
US20220096531A1 (en) 2022-03-31
CN104981234A (zh) 2015-10-14
ES2841434T3 (es) 2021-07-08
KR102227202B1 (ko) 2021-03-12
HRP20191382T1 (hr) 2019-11-15
AU2014212025A1 (en) 2015-08-20
HK1218517A1 (en) 2017-02-24
US20140221309A1 (en) 2014-08-07
KR20150113156A (ko) 2015-10-07
EP3517100B1 (en) 2020-09-09
HUE052793T2 (hu) 2021-05-28
SI2950783T1 (sl) 2019-10-30
CY1124054T1 (el) 2022-03-24
CA2898217C (en) 2021-08-31
CA2898217A1 (en) 2014-08-07
HUE044555T2 (hu) 2019-11-28
RU2015132974A (ru) 2017-03-06
JP2019112411A (ja) 2019-07-11
CN111419794A (zh) 2020-07-17
PT3517100T (pt) 2020-12-15
US20240285673A1 (en) 2024-08-29
JP6527468B2 (ja) 2019-06-05
JP6876079B2 (ja) 2021-05-26
RU2687275C2 (ru) 2019-05-13
EP2950783B1 (en) 2019-05-15
MX2015009924A (es) 2015-09-25

Similar Documents

Publication Publication Date Title
ZA201505026B (en) Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
IL241169B (en) Iris dilator
PL2946057T3 (pl) Zawias
EP2986798A4 (en) HINGE
SG11201508747XA (en) Tissue structure and manufacturing method therefor
SG11201505267SA (en) Jctvc-l0226: vps and vps_extension updates
SG11201509430WA (en) Heparan sulphates
GB201304837D0 (en) Implant trialling
PL3318278T3 (pl) Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu
GB201304835D0 (en) Implant trialling
PT2978326T (pt) Cigarros e a sua construção
GB2520480B (en) Improvements in hinge assemblies
SG10201709698TA (en) Heparan sulphate
IL229341A (en) Self-extinguishing cigarette for saving lives and preventing fire damage
GB201421052D0 (en) Artificial tissue
TWM475954U (en) Skin patch structure
GB201303796D0 (en) Condom
GB201309494D0 (en) Improvements in or relating to hinge assemblies
GB201303131D0 (en) Ocular prosthesis
GB201317662D0 (en) Composition comprising collagen and honey
GB2517211B (en) Conformable tissue expander
EP3003323A4 (en) POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
IL243842A0 (en) Hydrogel fibers and methods for their preparation
ZA201407945B (en) Hinge arrangement
GB201321018D0 (en) Improvements in hinge assemblies